Nicotinamide: Bright Potential in Glaucoma Management.
Silvia BabighianIrene GattazzoMaria Sole ZanellaAlessandro GalanFabiana D'EspositoMutali MusaCaterina GaglianoLucia LapennaMarco ZeppieriPublished in: Biomedicines (2024)
Nicotinamide holds promise as a novel therapeutic approach in glaucoma management, offering potential neuroprotective and IOP-lowering effects. The authors recommend more research to determine the nicotinamide efficacy, safe dosing parameters, and any long-term safety concerns in glaucoma patients.